Biodexa Pharmaceuticals Plc (BDRX) stock
BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.04−0.10 (-4.89%)
Close on Nov 18, 2026Market cap $4.60MP/E –Yield –
Biodexa Pharmaceuticals net income
Net income is the profit left for shareholders after every expense, interest and tax.
No net income figures for Biodexa Pharmaceuticals
Biodexa Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?